Dr. Goodenowe Dietary Therapeutics LLC announces FDA-governed development pathway for nutrient-based compounds February 20, 2026
Dr. Goodenowe Community Health Initiative Expands NeuroSupport Program to Serve Broader Neurodevelopmental Community February 19, 2026
Dr. Dayan Goodenowe Announces FDA Clinical Development Program for a Novel Alzheimer’s Therapeutic February 10, 2026
Dr. Dayan Goodenowe Announces Community Health Meal and Engagement Program for Moose Jaw Seniors January 30, 2026
Dr. Dayan Goodenowe and Autism Health Announce Dr. Goodenowe Childhood Neurodevelopmental Support Program – NeuroSupport December 22, 2025
Dr. Dayan Goodenowe Announces Partnership with Ruiya Group to Distribute Plasmalogen Precursors in China October 15, 2025
Dr. Dayan Goodenowe Announces ALS Health Challenge for All Residents of Saskatchewan Canada Living with ALS July 2, 2025
Dr. Dayan Goodenowe Announces $100 Million Community Health Investment in His Hometown of Moose Jaw April 22, 2025
